✦ LIBER ✦

Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma

✍ Scribed by M. Elizabeth Hammond; William T. Sause; Karen L. Martz; Miljenko V. Pilepich; Sucha O. Asbell; Philip Rubin; Robert P. Myers; George M. Farrow

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 610 KB
Volume: 63
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890201)63:3<461::aid-cncr2820630312>3.0.co;2-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostatic carcinoma metastatic to bone:

Prostatic carcinoma metastatic to bone: Sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material

✍ Niranjan T. Shah; Steven E. Tuttle; Stephan L. Storbel; Leena Gandhi 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

Decalcified bone marrow biopsies containing metastatic tumor from 36 patients were stained for prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) using the avidin biotin compIex (ABC) immunoperoxidase technique. Of these patients, 22 had known prostate primaries, ten had known nonp

Radiotherapy for localized prostate carc

Radiotherapy for localized prostate carcinoma : The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen

✍ Juanita M. Crook; Yasir A. Bahadur; R. Gregory Bociek; Gad A. Perry; Susan J. Ro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Background: The objective of this study was to correlate the failure pattern of localized prostate carcinoma after radiotherapy (rt) with pretreatment (pretx) psa and post-rt nadir psa, using systematic biopsies and serum psa in the assessment of outcome. ## Methods: From january 1990 to febru

Evaluation and comparison of two new pro

Evaluation and comparison of two new prostate carcinoma markers: Free-prostate specific antigen and prostate specific membrane antigen

✍ Gerald P. Murphy; Robert J. Barren; Sheila J. Erickson; Victoria A. Bowes; Rober 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 816 KB

## BACKGROUND. Two new prostate cancer markers, free-prostate specific antigen (f-PSA) and prostate specific membrane antigen (PSMA) were recently introduced. This report summarizes a prospective two-year multicenter test of their diagnostic or prognostic capabilities. Total PSA was also measured.

Prostate-specific antigen velocity and s

Prostate-specific antigen velocity and survival for patients with hormone-refractory metastatic prostate carcinoma

✍ Flora Rozhansky; Ming-Hui Chen; Michael C. Cox; William Dahut; William D. Figg; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

DIFFERENTIAL RESPONSIVENESS OF PROSTATIC

DIFFERENTIAL RESPONSIVENESS OF PROSTATIC ACID PHOSPHATASE AND PROSTATE-SPECIFIC ANTIGEN mRNA TO ANDROGEN IN PROSTATE CANCER CELLS

✍ Ming-Fong Lin; Ming-Shyue Lee; Renee Garcia-Arenas; Fen-Fen Lin 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 296 KB

## Abstract Androgens regulate the expression of both human prostatic acid phosphatase (PAcP) and prostate‐specific antigen (PSA), two major prostate epithelium‐specific differentiation antigens. Due to the important role of these two enzymes as prostate epithelium differentiation markers, we inves

Prostate specific antigen density in pat

Prostate specific antigen density in patients with histologically proven prostate carcinoma

✍ Mark Nishiya; Gary J. Miller; David H. Lookner; E. David Crawford 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 696 KB

Background. Prostate specific antigen (PSA) does not appear to have the specificity to distinguish between benign prostate hyperplasia and cancer when the PSA is low. PSA density is thought by many to improve the specificity for cancer; however, this theory remains controversial. Methods. The autho